Join +750K new investors every month who copy stock picks from billionaire's portfoliosSign Up Free

Insider Sale: Chief Medical Officer Elissa Charbonneau Sells 10,000 Shares of Encompass Health ...

Published 2024-05-24, 11:00 a/m
Insider Sale: Chief Medical Officer Elissa Charbonneau Sells 10,000 Shares of Encompass Health ...
EHC
-

GuruFocus - On May 24, 2024, Elissa Charbonneau, Chief Medical Officer of Encompass Health Corp (NYSE:EHC), executed a sale of 10,000 shares of the company at a price of $85.02 per share. This transaction was reported in a recent SEC Filing. Following this sale, the insider now owns 18,594.061 shares of Encompass Health Corp.

Encompass Health Corp specializes in integrated healthcare services, including both facility-based and home-based patient care. The company aims to deliver high-quality, cost-effective care across its network of inpatient rehabilitation hospitals, home health agencies, and hospice agencies.

Over the past year, Elissa Charbonneau has sold a total of 18,294 shares and has not made any purchases of the company's stock. The insider transaction history for Encompass Health Corp shows a trend with 1 insider buy and 6 insider sells over the past year.

As of the date of the insider's recent transaction, Encompass Health Corp's shares were trading at $85.02, giving the company a market cap of approximately $8.523 billion. The price-earnings ratio of the stock stands at 22.88, which is below the industry median of 25.52.

The stock's valuation, according to GuruFocus GF Value of $69.82, suggests that Encompass Health Corp is modestly overvalued with a price-to-GF-Value ratio of 1.22.

The GF Value is calculated considering historical trading multiples such as price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow, along with a GuruFocus adjustment factor based on past returns and growth, and future business performance estimates from Morningstar analysts.

This sale by the insider could be of interest to current and potential investors, providing insight into how insiders are interacting with their holdings in the company amidst its current market valuation and performance metrics.

This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.

This content was originally published on Gurufocus.com

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.